Cover Image

Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19

ObjectiveThe study aimed to report the efficacy and safety of anakinra treatment in patients with the refractory multisystemic inflammatory syndrome in children (MIS-C).MethodsThis is a cross-sectional retrospective study consisting of pediatric patients diagnosed with MIS-C who were treated with an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Şengül Çaǧlayan (Author), Hafize Emine Sönmez (Author), Gülçin Otar Yener (Author), Esra Baǧlan (Author), Kübra Öztürk (Author), Kadir Ulu (Author), Vafa Guliyeva (Author), Demet Demirkol (Author), Mustafa Çakan (Author), Semanur Özdel (Author), Hulya Bukulmez (Author), Nuray Aktay Ayaz (Author), Betül Sözeri (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience
by: Gülşah Kavrul Kayaalp, et al.
Published: (2023)

Real-Life Data From the Largest Pediatric Familial Mediterranean Fever Cohort
by: Kübra Öztürk, et al.
Published: (2022)

How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience
by: Semanur Ozdel, et al.
Published: (2023)

Editorial: Hereditary Periodic Fevers and Autoinflammatory Diseases
by: Hafize Emine Sönmez, et al.
Published: (2022)

Musculoskeletal Complaints: When Should We Consult a Pediatric Rheumatologist?
by: Hafize Emine Sönmez, et al.
Published: (2022)

Subcutaneous anakinra in the management of refractory MIS-C in France
by: Perrine Dusser, et al.
Published: (2024)

Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study
by: Francesco Licciardi, et al.
Published: (2023)

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease
by: Bilginer Y, et al.
Published: (2008)

Unveiling the uncommon: diagnostic journey of camurati-engelmann disease in a pediatric patient
by: Ayşenur Alkaya, et al.
Published: (2024)

Efficacy of sildenafil and high-dose anakinra in an MIS-C patient with pulmonary vasculitis: A case report
by: Francesco La Torre, et al.
Published: (2023)

Application of anakinra in inflammatory dermatoses
by: Xiaomei YOU, et al.
Published: (2024)

Continuous IV infusion of anakinra
by: Brittney N. Saunders, et al.
Published: (2023)

Paediatric Behçet's Disease: Data From A Single Center Experience In Turkey
by: Esra Bağlan, et al.
Published: (2021)

Possibilities for the use of anakinra in COVID-19
by: V. A. Otdelenov, et al.
Published: (2020)

The Role of Therapeutic Plasma Exchange (TPE) in Multisystem Inflammatory Syndrome in Children (MIS-C)
by: Gurkan Atay, et al.
Published: (2021)

A novel mutation in the proteoglycan 4 gene causing CACP syndrome: two sisters report
by: İlknur Bağrul, et al.
Published: (2023)

Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study
by: Betül Sözeri, et al.
Published: (2024)

Effect of anakinra on arthropathy in CINCA/NOMID syndrome
by: Kaneko Utako, et al.
Published: (2010)

Anakinra Therapy for Non-cancer Inflammatory Diseases
by: Giulio Cavalli, et al.
Published: (2018)

Efficacy of anakinra as a treatment for recurrent pericarditis
by: Sara Murias Loza, et al.
Published: (2018)

Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab
by: Angel Luis Salcedo-Mingoarranz, et al.
Published: (2023)

Intravenous administration of anakinra in children with macrophage activation syndrome
by: Omkar Phadke, et al.
Published: (2021)

Corrigendum: Anakinra Therapy for Non-cancer Inflammatory Diseases
by: Giulio Cavalli, et al.
Published: (2019)

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
by: Mahamid M, et al.
Published: (2011)

Anakinra and hepatotoxicity in pediatric rheumatology: a case series
by: Frederico Rajão Martins, et al.
Published: (2023)

Pilot Study of IL-1 Antagonist Anakinra for Treatment of Endometriosis
by: Sullender RT, et al.
Published: (2024)

Pharmacokinetics of Anakinra in Subjects of Heavier vs. Lighter Body Weights
by: Bing‐Bing Yang, et al.
Published: (2019)

Mis dos rostros
by: Dunis Argüelles Guevara
Published: (2023)

The mis-rule of three
by: Warden, Florence, 1857-1929

Budget impact analysis of anakinra in the treatment of familial Mediterranean fever in Italy
by: A Aiello, et al.
Published: (2023)

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
by: Santa-María V, et al.
Published: (2011)

The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis
by: L. Riente
Published: (2011)

Efficacy of Anakinra Treatment in two Moroccan Patients With Mevalonate Kinase Deficiency
by: Manal Souali, et al.
Published: (2023)

The Effect of Anakinra on Acrylamide-induced Peripheral Neuropathy and Neuropathic Pain in Rats
by: Alevtina Ersoy, et al.
Published: (2023)

Anakinra in Paediatric Rheumatology and Periodic Fever Clinics: Is the Higher Dose Safe?
by: Šárka Fingerhutová, et al.
Published: (2022)

Eficacia de anakinra como tratamiento de la pericarditis recurrente
by: Sara Murias Loza, et al.
Published: (2018)

Meckel's diverticulum in a strangulated umbilical hernia
by: Ilker Sengul, et al.
Published: (2011)

Familial Mediterranean Fever: Diagnosing as Early as 3 Months of Age
by: Gonca Keskindemirci, et al.
Published: (2014)

Multisystem inflammatory syndrome in children (MIS-C) and "Near MIS-C": A continuum?
by: Sarah Khafaja, et al.
Published: (2023)

Long-term control of refractory Schnitzler syndrome with anakinra: a case report
by: Hsien-Yi Chiu, et al.
Published: (2010)